Table of Contents Author Guidelines Submit a Manuscript
Journal of Nucleic Acids
Volume 2010, Article ID 632041, 9 pages
http://dx.doi.org/10.4061/2010/632041
Research Article

Development of a Novel Fluorescence Assay Based on the Use of the Thrombin-Binding Aptamer for the Detection of -Alkylguanine-DNA Alkyltransferase Activity

1Institute for Research in Biomedicine (IRB Barcelona) IQAC-CSIC, CIBER-BBN Networking Centre on Bioengineering Biomaterials and Nanomedicine, Cluster Building, Baldiri i Reixac 10, 08028 Barcelona, Spain
2Chemical and Physical Biology CIB (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain

Received 11 June 2010; Accepted 17 July 2010

Academic Editor: Ashis Basu

Copyright © 2010 Maria Tintoré et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Middleton and G. P. Margison, “Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway,” Lancet Oncology, vol. 4, no. 1, pp. 37–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Sabharwal and M. R. Middleton, “Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy,” Current Opinion in Pharmacology, vol. 6, no. 4, pp. 355–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Pegg and B. Singer, “Is O6-alkylguanine necessary for initiation of carcinogenesis by alkylating agents?” Cancer Investigation, vol. 2, p. 18, 1984. View at Google Scholar
  4. R. Saffhill, G. P. Margison, and P. J. O'Connor, “Mechanisms of carcinogenesis induced by alkylating agents,” Biochimica et Biophysica Acta, vol. 823, no. 2, pp. 111–145, 1985. View at Google Scholar · View at Scopus
  5. B. Singer, “O-Alkyl pyrimidines in mutagenesis and carcinogenesis: occurrence and significance,” Cancer Research, vol. 46, no. 10, pp. 4879–4885, 1986. View at Google Scholar · View at Scopus
  6. K. A. Jaeckle, H. J. Eyre, J. J. Townsend et al., “Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study,” Journal of Clinical Oncology, vol. 16, no. 10, pp. 3310–3315, 1998. View at Google Scholar · View at Scopus
  7. M. Belanich, M. Pastor, T. Randall et al., “Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine,” Cancer Research, vol. 56, no. 4, pp. 783–788, 1996. View at Google Scholar · View at Scopus
  8. R. S. Foote, S. Mitra, and B. C. Pal, “Demethylation of O6-methylguanine synthetic DNA polymer by an inducible activity in Escherichia coli,” Biochemical and Biophysical Research Communications, vol. 97, no. 2, pp. 654–659, 1980. View at Google Scholar · View at Scopus
  9. A. E. Pegg, “Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents,” Cancer Research, vol. 50, no. 19, pp. 6119–6129, 1990. View at Google Scholar · View at Scopus
  10. W. P. Tong, M. C. Kirk, and D. B. Ludlum, “Formation of the cross-link 1-[N3-deoxycytidyl],2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea,” Cancer Research, vol. 42, no. 8, pp. 3102–3105, 1982. View at Google Scholar · View at Scopus
  11. L. Yan, J. R. Donze, and L. Liu, “Inactivated MGMT by O6-benzylguanine is associated with prolonged G2/M arrest in cancer cells treated with BCNU,” Oncogene, vol. 24, no. 13, pp. 2175–2183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. T. P. Brent, P. J. Houghton, and J. A. Houghton, “O6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 9, pp. 2985–2989, 1985. View at Google Scholar · View at Scopus
  13. G. Tagliabue, L. Citti, G. Massazza, G. Damia, R. Giavazzi, and M. D'Incalci, “Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts,” Anticancer Research, vol. 12, no. 6B, pp. 2123–2125, 1992. View at Google Scholar · View at Scopus
  14. R. Pepponi, G. Marra, M. P. Fuggetta et al., “The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin,” Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 2, pp. 661–668, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Gerson, “Clinical relevance of MGMT in the treatment of cancer,” Journal of Clinical Oncology, vol. 20, no. 9, pp. 2388–2399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibáñez Koref, “Variability and regulation of O6-alkylguanine-DNA alkyltransferase,” Carcinogenesis, vol. 24, no. 4, pp. 625–635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Gerson, “MGMT: its role in cancer aetiology and cancer therapeutics,” Nature Reviews Cancer, vol. 4, no. 4, pp. 296–307, 2004. View at Google Scholar · View at Scopus
  18. M. E. Hegi, A.-C. Diserens, T. Gorlia et al., “MGMT gene silencing and benefit from temozolomide in glioblastoma,” The New England Journal of Medicine, vol. 352, no. 10, pp. 997–1003, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Esteller, J. Garcia-Foncillas, E. Andion et al., “Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents,” The New England Journal of Medicine, vol. 343, no. 19, pp. 1350–1354, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Pegg, K. Swenn, M.-Y. Chae, M. E. Dolan, and R. C. Moschel, “Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea,” Biochemical Pharmacology, vol. 50, no. 8, pp. 1141–1148, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. K. S. Srivenugopal, X.-H. Yuan, H. S. Friedman, and F. Ali-Osman, “Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea,” Biochemistry, vol. 35, no. 4, pp. 1328–1334, 1996. View at Google Scholar · View at Scopus
  22. M. Xu-Welliver and A. E. Pegg, “Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase,” Carcinogenesis, vol. 23, no. 5, pp. 823–830, 2002. View at Google Scholar · View at Scopus
  23. B. D. Wilson, M. Strauss, B. J. Stickells, E. G. Hoal-van Helden, and P. D. Van Helden, “An assay for O6-alkylguanine-DNA alkyltransferase based on restriction endonuclease inhibition and magnetic bead separation of products,” Carcinogenesis, vol. 15, no. 10, pp. 2143–2148, 1994. View at Google Scholar · View at Scopus
  24. M. E. Dolan, D. Schicchitiano, and A. E. Pegg, “Use of oligodeoxynucleotides containing O6-alkylguanine for the assay of O6-alkylguanine-DNA-alkyltransferase activity,” Cancer Research, vol. 48, no. 5, pp. 1184–1188, 1988. View at Google Scholar · View at Scopus
  25. A. M. Moser, M. Patel, H. Yoo, F. M. Balis, and M. E. Hawkins, “Real-time fluorescence assay for O6-alkylguanine-DNA alkyltransferase,” Analytical Biochemistry, vol. 281, no. 2, pp. 216–222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Wu, S. Hurst-Calderone, and K. W. Kohn, “Measurement of O6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restriction endonuclease inhibition,” Cancer Research, vol. 47, no. 23, pp. 6229–6235, 1987. View at Google Scholar · View at Scopus
  27. J. L. Huppert, “Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes,” Chemical Society Reviews, vol. 37, no. 7, pp. 1375–1384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Neidle, “The structures of quadruplex nucleic acids and their drug complexes,” Current Opinion in Structural Biology, vol. 19, no. 3, pp. 239–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. V. Hud, F. W. Smith, F. A. L. Anet, and J. Feigon, “The selectivity for K+ versus Na+ in DNA quadruplexes is dominated by relative free energies of hydration: a thermodynamic analysis by 1H NMR,” Biochemistry, vol. 35, no. 48, pp. 15383–15390, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Burge, G. N. Parkinson, P. Hazel, A. K. Todd, and S. Neidle, “Quadruplex DNA: sequence, topology and structure,” Nucleic Acids Research, vol. 34, no. 19, pp. 5402–5415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. W. Blume, V. Guarcello, W. Zacharias, and D. M. Miller, “Divalent transition metal cations counteract potassium-induced quadruplex assembly of oligo(dG) sequences,” Nucleic Acids Research, vol. 25, no. 3, pp. 617–625, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. A. G. Petrovic and P. L. Polavarapu, “Quadruplex structure of polyriboinosinic acid: dependence on alkali metal ion concentration, pH and temperature,” Journal of Physical Chemistry B, vol. 112, no. 7, pp. 2255–2260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. S. Mekmaysy, L. Petraccone, N. C. Garbett et al., “Effect of O6-methylguanine on the stability of G-quadruplex DNA,” Journal of the American Chemical Society, vol. 130, no. 21, pp. 6710–6711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Macaya, P. Schultze, F. W. Smith, J. A. Roe, and J. Feigon, “Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3745–3749, 1993. View at Google Scholar · View at Scopus
  35. O. S. Bhanot and A. Ray, “The in vivo mutagenic frequency and specificity of O6-methylguanine in φX174 replicative form DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 19, pp. 7348–7352, 1986. View at Google Scholar · View at Scopus
  36. F. M. Ruiz, R. Gil-Redondo, A. Morreale, Á. R. Ortiz, C. Fábrega, and J. Bravo, “Structure-based discovery of novel non-nucleosidic DNA alkyltransferase inhibitors: virtual screening and in vitro and in vivo activities,” Journal of Chemical Information and Modeling, vol. 48, no. 4, pp. 844–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. H. Caruthers, A. D. Barone, S. L. Beaucage et al., “Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method,” Methods in Enzymology, vol. 154, pp. 287–313, 1987. View at Google Scholar · View at Scopus
  38. H. Vu, C. McCollum, C. Lotys, and A. Andrus, “New reagents and solid support for automated oligonucleotide synthesis,” Nucleic Acids Symposium Series, no. 22, pp. 63–64, 1990. View at Google Scholar · View at Scopus
  39. J. J. Rasimas, A. E. Pegg, and M. G. Fried, “DNA-binding mechanism of O6-alkylguanine-DNA alkyltransferase: effects of protein and DNA alkylation on complex stability,” Journal of Biological Chemistry, vol. 278, no. 10, pp. 7973–7980, 2003. View at Publisher · View at Google Scholar · View at Scopus